| Literature DB >> 23574922 |
Kenneth Thorsen1, Jon Arne Søreide, Kjetil Søreide.
Abstract
BACKGROUND: Patients with perforated peptic ulcer (PPU) often present with acute, severe illness that carries a high risk for morbidity and mortality. Mortality ranges from 3-40% and several prognostic scoring systems have been suggested. The aim of this study was to review the available scoring systems for PPU patients, and to assert if there is evidence to prefer one to the other.Entities:
Mesh:
Year: 2013 PMID: 23574922 PMCID: PMC3626602 DOI: 10.1186/1757-7241-21-25
Source DB: PubMed Journal: Scand J Trauma Resusc Emerg Med ISSN: 1757-7241 Impact factor: 2.953
Scoring systems used for outcome prediction in perforated peptic ulcer
| 1987 | Patients with PPU | 30 day mortality | Presentation ≥ or <24 hours; presence of preoperative shock; level of comorbidity. | |
| 1992 | Patients with PPU | 30 day mortality | Presence of serious medical illness, acute renal failure, white blood cell count, male gender | |
| 2003 | Patients with PPU | 30 day mortality | Time from perforation to operation, mean systolic blood pressure preoperatively, heart rate, serum creatinine, age, comorbidity | |
| 2012 | Patients with PPU | 30 day mortality | Presentation ≥ or <24 hours; presence of preoperative shock; ASA score, presence of aids, active malignancy, liver failure; serum creatinine > 130 mmol/l | |
| 1941 | General surgical populations | Preoperative risk assessment for surgical patients | Degree of comorbidity and present systemic disease | |
| 1987 | General surgical populations | Prediction of 1 year mortality for hospitalized patients | Weighting of different comorbidities | |
| 2002 | General peritonitis | Peroperative prediction of outcome in patients with peritonitis | Age, gender, organ failure, duration of peritonitis, site of perforation, diffuse peritonitis, level of exudate | |
| 1985 | Critically ill patients | Prediction of outcome for ICU patients | Aids, metastatic cancer, liver failure, immunosuppression, chronic renal insufficiency, haemotologic malignancy, lymphoma, leukemia, age, heart rate, systolic blood pressure, respiratory rate, temperature, GCS, WBC, creatinine, blood gas, potassium, sodium, patient origin | |
| 1993 | Critically ill patients | Prediction of outcome for ICU patients | Aids, metastatic cancer, haemotologic malignancy, age, heart rate, systolic blood pressure, temperature, GCS, urine output, WBC, bilirubin, urea, Potassium, sodium, Patient origin | |
| 1993 | Critically ill patients | Prediction of outcome for ICU patients | Metastatic cancer, liver failure, chronic renal insufficiency, leukemia, age, acute renal failure, arrythmias, heart rate, GI bleeding, GCS, intracranial mass effect, cerebrovascular accident, cpr prior to admission, mechanical ventilation | |
| 1991 | Surgical patients | Prediction of outcome (mortality) for surgical patients | Respiratory history; cardiac signs; age; heart rate; systolic blood pressure; ecg; GCS; operative severity; multiple procedures, total blood loss, peritoneal soiling, finding of peroperative malignancy; elective or acute surgery, WBC, Hb, urea, potassium, sodium |
Peptic ulcer perforation score (PULP score).
American society of anesthesiologists (ASA) score.
Acute physiology and chronic health evaluation II (APACHE II).
Simplified acute physiology score II (SAPS II).
Mortality probability models II (MPM II).
Physiological and operative severity score for the enumeration of mortality and morbidity (POSSUM) score.
Glasgow coma scale (GCS).
White blood cell count (WBC).
Gastrointestinal bleeding (GI bleeding).
Hemoglobin (Hb).
Scoring accuracy of mortality prediction in PPU patients
| ASA | | 0.91 | | 0.78 | 0.73 |
| Boey | 0.85 | 0.86 | | 0.70 | 0.63 |
| Apache II | | | 0.87 | | 0.76 |
| SAPS II | | | 0.86 | | |
| MPM II | | | 0.98 | | |
| Hacateppe score | 0.72 | | | | |
| Jabalpur score | 0.92 | | | | |
| MPI | | 0.84 | | | |
| Modified Apache II | 0.84 | | | | |
| Modified MPI | 0.85 | | | | |
| PULP | | | | 0.83 | |
| Sepsis score | 0.69 | ||||
AUC denotes area under the curve . An AUC value > 0.8 is considered good, a range between 0.60-0.80 is considered as moderate, and an AUC value < 0.60 is regarded as poor.
ASA, American society of anesthesiologists (ASA) score.
APACHE II denotes Acute physiology and chronic health evaluation II.
Modified APACHE II, APACHE II calculated when no available blood gas.
SAPS, Simplified acute physiology score II (SAPS II).
MPM, Mortality probability models II (MPM II).
MPI denotes Mannheim peritonitis index.
Modified MPI, MPI calculated when no available blood gas.
PPU studies reporting on 30-day mortality
| Arici et al
[ | Italy | 1991-2004 | 147 | 14% | 52 (median) | Boey |
| Arveen et al
[ | India | 2006-2008 | 328 | 9% | 43 | ASA |
| Bae et al
[ | Korea | 2006-2007 | 4258 | 3% | 74% younger than 60 years of age | No score system |
| Bas et al
[ | Belgium | 1998-2004 | 97 | 5% | 39 | No score system |
| Bin-Taleb et al
[ | Yemen | 1997-2006 | 156 | 4% | 39 | No score system |
| Chalya et al
[ | Tanzania | 2006-2011 | 84 | 11% | 28 (median) | No score system |
| Christensen et al
[ | Denmark | 1991-2003 | 2061 | 25% | 61% older than 65 years of age | No score system |
| Dakubo et al
[ | Ghana | 1998-2002 | 326 | 11% | 41 | No score system |
| Egberts et al
[ | Germany | 1993-2005 | 261 | 24% | 67 (median) | Possum-phys |
| Forsmo et al
[ | Norway | 1992-2003 | 102 | 22% | 71 (median) | ASA |
| Hemmer et al
[ | The Netherlands | 2000-2005 | 272 | 16% | 62 | ASA |
| Kamani et al
[ | Iran | 1996-2005 | 56 | 5% | 50 | No score system |
| Kim et al
[ | Korea | 2005-2010 | 142 | 6% | 57 | ASA |
| Koc et al
[ | Turkey | 2005-2006 | 75 | 11% | 44 (median) | APACHE II, APACHE III SAPS II, MPM II |
| Kocer et al
[ | Turkey | 2001-2004 | 269 | 9% | 43 | ASA |
| Kujath
[ | Germany | 1996-2000 | 102 | 14% | 69 | ASA |
| Larkin et al
[ | Ireland | 1998-2007 | 76 | 20% | 60 | ASA |
| Lohsiriwat et al
[ | Thailand | 2001-2006 | 152 | 9% | 52 | Boey, ASA, MPI |
| Makele et al
[ | Finland | 1979-2000 | 280 | 14% | 58 | Boey, ASA, MPI |
| Mishra et al
[ | India | 1999-2001 | 140 | 11% | 39 | Apache II |
| MPI | ||||||
| Jabalpur | ||||||
| Montalvo-Jave et al
[ | Mexico | 2006-2008 | 30 | 17% | 57 | No score system |
| Muslu et al
[ | Turkey | 1998-2005 | 126 | 4% | 51 | No score system |
| Møller et al
[ | Denmark | 2003-2009 | 2668 | 27% | 71 (median) | PULP, ASA, Boey |
| Nasio/Saidi
[ | Kenya | 2005-2006 | 44 | 9% | 35 | No score system |
| Noguiera et al
[ | Portugal | 1990-2000 | 210 | 10% | 53 (median) | No score system |
| Rajesh et al
[ | India | 2006-2011 | 180 | 13% | <50 years | Apache II |
| Boey | ||||||
| Subedi et al
[ | Nepal | 2002-2004 | 145 | 7% | 46 | No score system |
| Taha et al
[ | Scotland | 1997-2006 | 270 | 19% | 64 (median) | Charlson comorbidity index |
| Thorsen et al
[ | Norway | 2003-2009 | 114 | 16% | 67 (median) | ASA |
| Boey |
Table sorted alphabetically by study author’s name.
Mortality rates and age are rounded up/down.
American society of anesthesiologists (ASA) score.
Acute physiology and chronic health evaluation II (APACHE II).
Simplified acute physiology score II (SAPS II).
Mortality probability models II (MPM II).
Mannheim peritonitis index (MPI).
Peptic ulcer perforation (PULP) score.
Physiological and operative severity score for the enumeration of mortality and morbidity physical sub-score (POSSUM-phys score).